Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
Healthcare companies were featured more than any other sector on Fortune’s 2025 list of America’s most innovative companies, ...
How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.
The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...